AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.45B
AIVCX
Price
$18.97
Change
-$0.07 (-0.37%)
Updated
Jun 5 closing price
Net Assets
2.39B
Interact to see
Advertisement

AEPCX vs AIVCX

Header iconAEPCX vs AIVCX Comparison
Open Charts AEPCX vs AIVCXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.45B
American Funds International Vntg C
Price$18.97
Change-$0.07 (-0.37%)
VolumeN/A
Net Assets2.39B
AEPCX vs AIVCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. AIVCX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AIVCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. AIVCX (2.39B). AIVCX pays higher dividends than AEPCX: AIVCX (0.38) vs AEPCX (0.32). AEPCX was incepted earlier than AIVCX: AEPCX (24 years) vs AIVCX (6 years). AIVCX (1.70) is less costly to investors than AEPCX (1.59). AEPCX is a more actively managed with annual turnover of: 30.00 vs. AIVCX (20.00). AEPCX (250) and AIVCX (250) have matching initial minimum investment requirements. AIVCX annual gain was more profitable for investors over the last year : 10.65 vs. AEPCX (2.04). AIVCX return over 5 years is better than : 37.92 vs. AEPCX (14.22).
AEPCXAIVCXAEPCX / AIVCX
Total Expense Ratio1.591.7094%
Annual Report Gross Expense Ratio1.591.7094%
Fund Existence24 years6 years-
Gain YTD12.50218.11469%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets133B2.39B5,570%
Annual Yield % from dividends0.320.3886%
Returns for 1 year2.0410.6519%
Returns for 3 years14.8234.5343%
Returns for 5 years14.2237.9237%
Returns for 10 years20.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.